Size exclusion chromatography combined with multi-angle light scattering (SEC-MALS) has become a powerful analytical approach for characterizing biomolecules under native conditions. It enables direct measurement of molar mass, aggregation, fragment profiles, and conjugation ratios — without relying on column calibration assumptions.
In a recent technical session hosted by Venture Center’s bioanalytical facility, experts demonstrated how SEC-MALS strengthens workflows for monoclonal antibodies, biosimilars, antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), glycoproteins, pegylated proteins, and peptide therapeutics. The method supports both research and quality workflows by delivering absolute molar mass and composition data in a single run.
From Venture Center’s “Only One Analytical Technique” Talk Series with Dr. Leo Hongjiang Liu, Senior Scientist, Waters Corporation
Why Traditional SEC Calibration Can Mislead Molar Mass Results
Conventional SEC relies on column calibration curves that relate elution volume to molar mass. This approach works only when several strict assumptions hold true:
- Calibrant and analyte have the same conformation
- Calibrant and analyte have the same density
- No interaction with column packing
- No reversible self-interaction
In practice, these assumptions are often violated. Different polymers — and even different versions of the same polymer — can produce very different molar mass estimates at the same elution volume. Proteins and antibodies may also interact with column hardware or packing material, shifting retention time and distorting estimates.
This is why elution order alone cannot reliably confirm molar mass identity.
How SEC-MALS Solves the Problem
SEC-MALS adds multi-angle light scattering detection after chromatographic separation. Instead of estimating molar mass from elution volume, it measures it directly from physical light-scattering behavior.
The principle is straightforward:
- All particles scatter light when illuminated by a laser
- Scattered intensity is proportional to concentration × molar mass × refractive index increment
- Concentration is measured online (UV and/or RI detector)
- Light scattering is measured directly
- Software calculates molar mass at each time slice across the peak
This produces absolute molar mass values independent of retention time.Because molar mass is calculated continuously across the chromatographic peak, users can detect heterogeneity, co-elution, fragments, and aggregates with high confidence.
SEC-MALS for Monoclonal Antibodies and Biosimilars
For antibody analysis, SEC-MALS enables:
- Monomer, dimer, and trimer identification
- Fragment detection
- Aggregate quantification
- Identity confirmation independent of elution shifts
Examples presented showed cases where antibodies eluted later than expected due to column interaction, yet SEC-MALS still reported the correct molar mass. This removes ambiguity when peak position alone is misleading.
In biosimilar comparison workflows, platform SEC-MALS methods allow multiple antibodies to be analyzed without redeveloping column calibration — because molar mass is measured directly rather than inferred.
Peak asymmetry can also be investigated using molar mass traces across the peak. When apparent molar mass increases with injection concentration, it signals reversible self-association, which may create stability risks at higher formulation concentrations.
Detecting Fragments and Native Aggregates
Because SEC-MALS operates under native buffer conditions, it detects:
- Native aggregates
- Native fragments
- Reversible associations
- Irreversible aggregates
This differs from denaturing MS approaches, where formulation context is lost. SEC-MALS can therefore reveal aggregation behavior that only appears in final formulation buffers.
Conjugate Analysis: ADCs and AOCs
A major strength of SEC-MALS is conjugate characterization. When two components contribute different detector responses (for example UV and RI), the system can resolve:
- Protein molar mass
- Modifier molar mass
- Total molar mass
- Stoichiometry ratios
Applications demonstrated include:
Antibody-Drug Conjugates (ADCs)
SEC-MALS can measure:
- DAR (drug-antibody ratio)
- DAR distribution across monomer, dimer, and aggregate peaks
- Whether higher-DAR species aggregate more strongly
- Co-eluting DAR variants
SEC-MALS DAR analysis is especially useful in process development, where many in-process samples must be screened rapidly under native conditions. Mass spectrometry remains the regulatory gold standard, but SEC-MALS provides faster routine insight for development workflows.
Hydrophobic interaction chromatography (HIC-MALS) adds another separation dimension, resolving DAR species by hydrophobicity instead of size.
Antibody-Oligonucleotide Conjugates (AOCs)
SEC-MALS and ion-exchange-MALS can quantify:
- Antibody-oligo ratio
- Aggregate stoichiometry
- Payload heterogeneity
- Stability changes after stress incubation
Charge-based separation helps resolve payload number variants that SEC cannot fully separate by size alone.
Pegylated and Glycosylated Proteins
SEC-MALS distinguishes:
- Protein backbone mass
- PEG or glycan mass
- Changes in conjugation level
- Dimerization vs conjugation loss
Examples showed that stress conditions increased dimer fraction while preserving PEG stoichiometry — proving the change was aggregation, not de-pegylation. It also differentiated glycosylation differences between expression systems while confirming identical protein backbone mass.
Peptide Therapeutics and GLP-1 Analogs
Multi-angle light scattering applies equally to peptides. Case examples included GLP-1 analog drugs, where SEC-MALS revealed:
- Native oligomeric bundles (hexamers, higher assemblies)
- Trimer–tetramer equilibria
- Formulation-dependent association shifts
- Reversible vs irreversible assemblies
- DS vs DP aggregation differences
By running both native and denaturing SEC-MALS, users can distinguish:
- Reversible higher-order assemblies
- Covalent aggregates
- True monomer content
This provides strong in-vitro similarity evidence between drug substance and drug product.
Normalization and Detector Setup — Practical Notes
Detector normalization in MALS is solvent-dependent, not analyte-dependent. Small isotropic scatterers (well below ~10 nm radius) can be used as normalization standards. The normalization factor remains valid as long as the mobile phase composition does not change.
This simplifies deployment across proteins, peptides, and conjugates using the same buffer system.
Multi-Attribute Quantitation in One Run
A key takeaway from the session is that SEC-MALS supports multi-attribute quantitation in a single assay:
- Absolute molar mass
- Aggregation level
- Fragment content
- Conjugation stoichiometry
- Payload ratio
- Composition
- Size trends
- Reversible interactions
Instead of running multiple orthogonal assays, many attributes can be obtained from one integrated workflow.
SEC-MALS Capabilities at Venture Center
Venture Center’s Center for Biopharma Analysis (CBA) operates GLP-compliant and NABL-accredited analytical facilities supporting advanced biomolecular characterization workflows, including SEC-based multi-detector analysis for proteins, peptides, and conjugates. The facility supports both structural and functional characterization programs along with scientific consultation and method support.
Teams working on biologics, biosimilars, ADCs, conjugates, and peptide therapeutics can engage the Venture Center analytical group for method development, characterization, and comparative studies.
Email: rutuja.patil@venturecenter.co.in
Explore our services here
Interested in a SEC-MALS session for your characterization needs Book Now